/

Non-hormonal

FDA-approved

Elinzanetant (Lynkuet)

A dual NK1/NK3 blocker for hot flashes and sleep.

VIDEO LESSON

IN THE STUDIO
Dr. Tahir is recording this lesson.
Check back soon. New lessons are added regularly.
ANIMATED EXPLAINER · ELINZANETANT
STEP 1 OF 4
Two pathways
NK1 and NK3 receptors both influence the thermostat and sleep.

How it's taken

• Once daily at bedtime

Side effects at a glance

• Headache and fatigue

• Sleepiness and dizziness: avoid driving if affected

Monitoring

Your clinician will review interactions, particularly with medicines that strongly affect the liver enzyme CYP3A4, and follow the label's lab guidance.

Good to know

Trials measured improvements in sleep disturbance as well as hot flashes. OASIS-4 studied women taking endocrine therapy for breast cancer.

AT A GLANCE

Class

Non-hormonal

Brand names

Lynkuet

Status

FDA-approved

Reviewed by

Farhan Tahir, MD

Is this medicine right for you?

Prescription medicines need individual medical advice. Dr. Tahir’s team offers consults through Youthful Medicine.

MECHANISM

How it works

Blocks both neurokinin-1 and neurokinin-3 receptors in the hypothalamus, calming the overactive temperature-control signal behind hot flashes. Taken as a 120 mg capsule dose once daily at bedtime.

KNDy NEURONTemperaturecenterNK BLOCKER

When estrogen falls, KNDy neurons in the hypothalamus overfire neurokinin signals into the brain’s temperature center. NK3 (and NK1) blockers quiet that signal without hormones.

THE EVIDENCE

What the research actually shows.

EVIDENCE SUMMARY

Approved by the FDA on October 24, 2025 for moderate to severe hot flashes caused by menopause. In the OASIS 1 and 2 trials it reduced hot-flash frequency and severity versus placebo and improved sleep disturbance, and the 52-week OASIS 3 trial showed the benefit was sustained.

KEY TRIALS

OASIS 1 · OASIS 2 · OASIS 3

TYPICAL RESULT

Fewer, milder hot flashes plus better sleep scores

SAFETY

Risks, side effects and who should avoid it

The most common side effects are headache, fatigue, dizziness and sleepiness. It can depress the central nervous system, so avoid driving or alcohol until you know how it affects you. Not for use in pregnancy.

This summary is not a complete list of risks. Read the official prescribing information and discuss your own history with your clinician.

KEY REFERENCE

LYNKUET (elinzanetant) capsules. U.S. prescribing information, October 2025.

Educational content only, reviewed by Farhan Tahir, MD. Not individual medical advice. Medicines named here require a prescription and medical supervision.